Organization | Kuwait University

Kuwait University Report issue

Academic/Hospital Phase 1 Phase 2 Phase 4

Organization Overview

First Clinical Trial

2011

NCT01438866

First Marketed Drug

None

First NDA Approval

None

Last Known Activity

2023

Timeline

NOW

Now

Alternative names

Faculty of Dentistry, Kuwait University | KUWAIT UNIVERISTY | Kuwait University

Active Ingredients

Drugs in Phase 4 Trials (2)

pioglitazone (actos) (1 trial)

sodium chloride (2 trials)

Drugs in Phase 2 Trials (3)

autologous microbiome (1 trial)

sorbitol (1 trial)

xylitol (1 trial)

Drugs in Phase 1 Trials (2)

methylphenidate (ritalin) (1 trial)

modafinil (provigil) (1 trial)

Drugs in Other Trials (4)

chlorhexidine (hibitane) (1 trial)

miswak (1 trial)

potassium iodide (thyro-block) (1 trial)

silver diammine fluoride (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)

Bacterial Infections (Phase 2)

Dental Plaque (Phase 2)

Overview

Highest Phase: Phase 4
# of Trials: 7
# of Trial APIs: 11